STENTiT

About STENTiT

STENTiT is a medical device spin-off company from the Dutch Eindhoven University of Technology, focusing on the development of regenerative endovascular implants. These bioresorbable devices trigger a natural healing response by the circulating blood cells, in which the implant is being replaced by new vascular tissue to restore the artery from the inside-out. Since the establishment of the company in 2017, STENTiT has received broad international recognition and awards for its high-potential approach, covering world leading stages. As the company is currently going through the next translational phases, STENTiT is on its way to fulfill its ambition to become the new standard in endovascular treatment, providing a life-lasting solution for millions of patients around the world.

Address

• Headquarters

  5612AP EindhovenNoord-Brabant, Netherlands

Team by function

Based on 12 public job profiles as of 3 September 2026.

• Research / R&D4
• Consulting / Advisory1
• Engineering / Software Development1
• Executive / C-Suite1
• Finance / Accounting1
• Healthcare / Medical1
• Manufacturing / Production1
• Other / Unclassifiable1
• Sales1